ConductScience.org, home

Paper1089999

Glucagon: role in the hyperglycemia of diabetes mellitus.

Dobbs R and 7 others. Science, 1975. Cited by 243 papers, by iCite.

Cite this record

ConductScience Library. Glucagon: role in the hyperglycemia of diabetes mellitus. Papers, record 1089999. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/1089999

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Glucagon: role in the hyperglycemia of diabetes mellitus.
PubMed
Journal
Science
PubMed
Year
1975
PubMed
Publication types
Journal Article, Research Support, U.S. Gov't, Non-P.H.S.
PubMed
Citations, by iCite
243
iCite
Relative citation ratio, by iCite
5.95
iCite
Revised in PubMed
2019-06-18
PubMed

Authors8

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Dobbs RR
2Sakurai HH
3Sasaki HH
4Faloona GG
5Valverde II
6Baetens DD
7Orci LL
8Unger RR

Source PubMed

Download CSV of authors

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Diabetes MellitusMajor topic
GlucagonMajor topic
Growth Hormone-Releasing HormoneMajor topic
HyperglycemiaMajor topic
Animals
Arginine
Diabetes Complications
Diabetes Mellitus, Experimental
Dogs
Insulin
Oligopeptides
Pancreatectomy

Source PubMed

Download CSV of topics

Cited by73

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 243 citations.

PMIDTitleJournalYearIn PapersSource
42651699For Weight Loss: Why Do GLP-1 Agonists Work, and How Can We Make Them Work Better?Biology (Basel)2026https://conductscience.org/library/papers/42651699PubMed
41206016Glucagon, the Alpha Cell, and Potential Targets for Diabetes Treatment.Endocrinology2025https://conductscience.org/library/papers/41206016PubMed
40854221Glucagon Receptor Deficiency Causes Early-Onset Hepatic Steatosis.Diabetes2025https://conductscience.org/library/papers/40854221PubMed
37258572The YTHDC1/GLUT3/RNF183 axis forms a positive feedback loop that modulates glucose metabolism and bladder cancer progression.Exp Mol Med2023https://conductscience.org/library/papers/37258572PubMed
36729958A newly developed glucagon sandwich ELISA is useful for more accurate glucagon evaluation than the currently used sandwich ELISA in subjects with elevated plasma proglucagon-derived peptide levels.J Diabetes Investig2023https://conductscience.org/library/papers/36729958PubMed
35784565Role of Glucagon and Its Receptor in the Pathogenesis of Diabetes.Front Endocrinol (Lausanne)2022https://conductscience.org/library/papers/35784565PubMed
32259078Inventing Liraglutide, a Glucagon-Like Peptide-1 Analogue, for the Treatment of Diabetes and Obesity.ACS Pharmacol Transl Sci2019https://conductscience.org/library/papers/32259078PubMed
31967385Flavone Hispidulin Stimulates Glucagon-Like Peptide-1 Secretion and Ameliorates Hyperglycemia in Streptozotocin-Induced Diabetic Mice.Mol Nutr Food Res2020https://conductscience.org/library/papers/31967385PubMed
31936192Revisiting the Pharmacological Value of Glucagon: An Editorial for the Special Issue "The Biology and Pharmacology of Glucagon".Int J Mol Sci2020https://conductscience.org/library/papers/31936192PubMed
30216981The Flavonoid Kaempferol Ameliorates Streptozotocin-Induced Diabetes by Suppressing Hepatic Glucose Production.Molecules2018https://conductscience.org/library/papers/30216981PubMed
29773871The somatostatin-secreting pancreatic δ-cell in health and disease.Nat Rev Endocrinol2018https://conductscience.org/library/papers/29773871PubMed
29438473In Uncontrolled Diabetes, Hyperglucagonemia and Ketosis Result From Deficient Leptin Action in the Parabrachial Nucleus.Endocrinology2018https://conductscience.org/library/papers/29438473PubMed
29322286Hyperglycemia and aberrant O-GlcNAcylation: contributions to tumor progression.J Bioenerg Biomembr2018https://conductscience.org/library/papers/29322286PubMed
28239611Pleotropic Acute and Chronic Effects of Leptin to Reverse Type 1 Diabetes.Postdoc J2017https://conductscience.org/library/papers/28239611PubMed
27901482Hyperglycemia triggers HIPK2 protein degradation.Oncotarget2017https://conductscience.org/library/papers/27901482PubMed
27362798ZnCl2 sustains the adriamycin-induced cell death inhibited by high glucose.Cell Death Dis2016https://conductscience.org/library/papers/27362798PubMed
27115412Glucagon is the key factor in the development of diabetes.Diabetologia2016https://conductscience.org/library/papers/27115412PubMed
26969486The role of leptin in diabetes: metabolic effects.Diabetologia2016https://conductscience.org/library/papers/26969486PubMed
25850661Islet α cells and glucagon--critical regulators of energy homeostasis.Nat Rev Endocrinol2015https://conductscience.org/library/papers/25850661PubMed
25633417Evidence That in Uncontrolled Diabetes, Hyperglucagonemia Is Required for Ketosis but Not for Increased Hepatic Glucose Production or Hyperglycemia.Diabetes2015https://conductscience.org/library/papers/25633417PubMed

See all 73 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/1089999

GET https://conductscience.org/api/papers/v1/1089999/cited_by?page=2